IRLAB Therapeutics AB (publ) (IRLAB-A) — Strategic Asset Allocation Index
IRLAB Therapeutics AB (publ) (IRLAB-A) has a Strategic Asset Allocation Index of 17.8% as of December 2025. Strategic assets (PP&E of Skr5.47 Million plus long-term investments of Skr-) total Skr5.47 Million, measured against net assets of Skr30.72 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
IRLAB Therapeutics AB (publ) Strategic Asset Allocation Index (2016–2025)
This chart shows how IRLAB Therapeutics AB (publ)'s Strategic Asset Allocation Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 17.8%, representing strategic assets of Skr5.47 Million against net assets of Skr30.72 Million SEK. Explore IRLAB-A cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for IRLAB Therapeutics AB (publ) (2016–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for IRLAB Therapeutics AB (publ) from 2016 to 2025, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IRLAB Therapeutics AB (publ) (IRLAB-A) total market value.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 17.8% | Skr5.47 Million | Skr5.47 Million | Skr- | Skr30.72 Million | ▼ -12.2 pp |
| 2024 | 30.0% | Skr9.79 Million | Skr9.79 Million | Skr- | Skr32.63 Million | ▲ +24.2 pp |
| 2023 | 5.8% | Skr6.67 Million | Skr6.67 Million | Skr- | Skr115.76 Million | ▲ +3.0 pp |
| 2022 | 2.8% | Skr8.01 Million | Skr8.01 Million | Skr- | Skr290.83 Million | ▲ +0.7 pp |
| 2021 | 2.1% | Skr8.35 Million | Skr8.35 Million | Skr- | Skr399.48 Million | ▲ +0.8 pp |
| 2020 | 1.2% | Skr4.32 Million | Skr4.32 Million | Skr- | Skr347.88 Million | ▼ -2.0 pp |
| 2019 | 3.3% | Skr5.92 Million | Skr5.92 Million | Skr- | Skr181.83 Million | ▲ +2.7 pp |
| 2018 | 0.6% | Skr1.20 Million | Skr1.20 Million | Skr- | Skr212.48 Million | ▲ +0.3 pp |
| 2017 | 0.3% | Skr478.00K | Skr478.00K | Skr- | Skr155.00 Million | ▼ -0.3 pp |
| 2016 | 0.6% | Skr649.00K | Skr649.00K | Skr- | Skr103.89 Million | — |